Copertina

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Faheem Arshad, M. M. Samim, Paras Rohidas Borse, Ravi G. Shankar, R. Bharath, B. H. Gagantej, Pooja Mailankody, Subasree Ramakrishnan, Sarada Subramanian, Suvarna Alladi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Emerging role of serum biomarkers in neurodegenerative dementias in a diverse context
di: Faheem Arshad, et al.
Pubblicazione: (2024)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
di: Marijke E. Stokkel, et al.
Pubblicazione: (2026)

Potential Eligibility for Lecanemab in a Cohort of Alzheimer’s Dementia Patients from India
di: Suvarna Alladi, et al.
Pubblicazione: (2025)

Correct Information Units in Narrative Discourse as an Indicator of Dementia
di: Aparna Lalana Venugopal, et al.
Pubblicazione: (2025)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
di: Renée C. Groechel, et al.
Pubblicazione: (2024)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
di: Soheil Mohammadi, et al.
Pubblicazione: (2025)

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
di: Frédéric Blanc, et al.
Pubblicazione: (2025)

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
di: Saki Nakashima, et al.
Pubblicazione: (2026)

Eligibility for anti‐amyloid treatment in a multiethnic community‐based study
di: Lydia Trudel, et al.
Pubblicazione: (2026)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
di: John T. O'Brien
Pubblicazione: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
di: Darren M. Lipnicki, et al.
Pubblicazione: (2026)

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
di: Dejia Yin, et al.
Pubblicazione: (2026)

Reduced plasma hexosylceramides in frontotemporal dementia are a biomarker of white matter integrity
di: Oana C. Marian, et al.
Pubblicazione: (2025)

Neurology and inflammatory‐associated plasma protein biomarkers linked to dementia progression, brain aging pathology
di: Noah Schweitzer, et al.
Pubblicazione: (2026)

Ethics of disclosure of onset‐predictive biomarker test results for genetic frontotemporal dementia in the research context
di: Charlotte H. Graafland, et al.
Pubblicazione: (2025)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
di: Iolanda Lázaro, et al.
Pubblicazione: (2024)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
di: Katharina Bolsewig, et al.
Pubblicazione: (2024)

Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
di: Tosca O. E. de Crom, et al.
Pubblicazione: (2024)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
di: Ihab Hajjar, et al.
Pubblicazione: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
di: Yuhan Xie, et al.
Pubblicazione: (2025)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
di: Lars Frings, et al.
Pubblicazione: (2025)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
di: Christopher Gonzalez Corona, et al.
Pubblicazione: (2026)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
di: Robert Perneczky, et al.
Pubblicazione: (2025)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
di: Patrick H. Luckett, et al.
Pubblicazione: (2026)

Proteomic profiling identifies serpin G1, ApoA‐II, and LBP as potential biomarkers of dementia in an Egyptian cohort
di: Shimaa A. Heikal, et al.
Pubblicazione: (2025)

Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
di: Kazuki Yamada, et al.
Pubblicazione: (2026)

Accuracy of pattern‐based dementia diagnostic protocols: Using longitudinal data to infer etiology of Alzheimer's disease and related dementias compared to stroke or normal aging
di: Sean A. P. Clouston, et al.
Pubblicazione: (2025)

Artificial intelligence‐based diagnosis in fetal pathology using external ear shapes
di: Quentin Hennocq, et al.
Pubblicazione: (2024)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
di: Zheng Long Lee, et al.
Pubblicazione: (2026)

APOE ε4, modifiable risk factors, and dementia in community‐based older Japanese adults
di: Masaya Kumamoto, et al.
Pubblicazione: (2026)

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria
di: Leonardo E. Ariello, et al.
Pubblicazione: (2025)

Network‐based cortical atrophy predicts longitudinal clinical decline in sporadic behavioral variant frontotemporal dementia
di: Yuta Katsumi, et al.
Pubblicazione: (2026)

Intracranial arteriosclerosis is not associated with cerebral amyloid deposition
di: Anna M. Streiber, et al.
Pubblicazione: (2024)

A capture‐based method of prenatal cell‐free DNA screening for autosomal recessive non‐syndromic hearing loss
di: Qian Mu, et al.
Pubblicazione: (2024)

Association of enlarged perivascular spaces with cognitive function in dementia‐free older adults: A population‐based study
di: Mingqing Zhao, et al.
Pubblicazione: (2024)

Fully automated MRI‐based analysis of the locus coeruleus in aging and Alzheimer's disease dementia using ELSI‐Net
di: Max Dünnwald, et al.
Pubblicazione: (2025)

Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
di: Chloe Walsh, et al.
Pubblicazione: (2026)

Clinical experience of next generation sequencing based expanded carrier screening in high‐risk couples from a tertiary healthcare center in Pakistan
di: Fizza Akbar, et al.
Pubblicazione: (2024)

Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology
di: Ece Bayram, et al.
Pubblicazione: (2025)

Development of amyloid‐negative neuropsychological norms using GAMLSS
di: Sara Rubio‐Guerra, et al.
Pubblicazione: (2025)